Biogen will present detailed Phase 2 study data for its experimental Alzheimer’s drug diranersen at a conference in London.
Early in the progression of Alzheimer's and other neurodegenerative diseases, DNA inside neurons starts showing signs of ...
That is why scientists at the Sudha Gopalakrishnan Brain Centre (SGBC) at the Indian Institute of Technology, Madras (IIT-M) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results